| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/01/2008 | US7314915 Fluorescent proteins |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314748 Dormant bacteria in the fibers that can digest odor-causing matter such as spills; Bacillus megaterium, Bacillus pasteurii, Bacillus laevolacticus and Bacillus amyloliquefaciens; controlling odor associated with deposits on surfaces, particularly spills of organic material on surfaces, carpets |
| 01/01/2008 | US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors |
| 01/01/2008 | US7314746 Apparatus and method for preparative scale purification of nucleic acids |
| 01/01/2008 | US7314743 Xylanases having increased stability in harsh industrial environments, such as increased pH and/or temperature |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314740 Method of separating poly-3-hydroxyalkanoic acid |
| 01/01/2008 | US7314739 Lipase variants |
| 01/01/2008 | US7314738 Nucleotide sequences coding hydantoinase/hydrolases for producing pharmaceuticals, chemical industrial products and food; for producing the D-amino acid efficiently from the 5-substituted hydantoin |
| 01/01/2008 | US7314733 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders |
| 01/01/2008 | US7314732 Drug and manufacturing method of same |
| 01/01/2008 | US7314730 Identifying modulator which inhibit membrane bound protease activity for use in treatment and prevention of atherosclerosis, infections, inflammation, cell proliferative, neurodegenerative and respiratory system disorders |
| 01/01/2008 | US7314719 to soil microorganism (Streptomyces, Bacillus, and Pseudomonas) that produce agriculturally and/or medically useful antibiotics and biologically active substances |
| 01/01/2008 | US7314710 Method for replicating the hepatitis C virus |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 01/01/2008 | US7314619 Polypeptide for use in the treatment of cancer |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 12/27/2007 | WO2007149894A2 Production of d-lactic acid with yeast |
| 12/27/2007 | WO2007149791A2 System for isolating biomolecules from a sample |
| 12/27/2007 | WO2007149327A2 Composition and methods for improving the production of fermentation operations |
| 12/27/2007 | WO2007149012A1 Live tularemic vaccine nik-sp.f. tularensis |
| 12/27/2007 | WO2007148926A1 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene |
| 12/27/2007 | WO2007148819A1 Cosmid vector for plant transformation and use thereof |
| 12/27/2007 | WO2007148723A1 Gene that regulates color of shell of pearl oyster and pearl and protein encoded by the same |
| 12/27/2007 | WO2007148488A1 Peptide for reactivation of inactivated gene |
| 12/27/2007 | WO2007148412A1 Novel fki-3389 substance and method for producing the same |
| 12/27/2007 | WO2007148363A1 Salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof |
| 12/27/2007 | WO2007148121A2 Nucleic acid molecules encoding an enzyme that degrades long-chain n-alkanes |
| 12/27/2007 | WO2007147945A1 Modified beta-lactamase and method for its preparation |
| 12/27/2007 | WO2007147827A2 Production of pravastatin |
| 12/27/2007 | WO2007147256A1 Fatty acid hydroxylases and uses thereof |
| 12/27/2007 | WO2006108138A3 Systems and methods for the isolation and identification of microorganisms from hydrocarbon deposits |
| 12/27/2007 | WO2005099390A3 Compositions and methods for reverse transcription |
| 12/27/2007 | WO2005069859A3 Compositions and methods for modulating dhr96 |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070300327 Plant enzymes for bioconversion |
| 12/27/2007 | US20070300313 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/27/2007 | US20070299019 Macrolides and methods for producing same |
| 12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
| 12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
| 12/27/2007 | US20070298498 Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof |
| 12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
| 12/27/2007 | US20070298492 Novel PTH responsive gene |
| 12/27/2007 | US20070298491 Human Secreted Proteins |
| 12/27/2007 | US20070298484 Method and Device for Thermal Conditioning of a Cell |
| 12/27/2007 | US20070298483 Deletion in glgA gene in carotenogenic microbial host cell engineered to recombinantly produce at least one carotenoid compound (Methylomonas sp. and Escherichia coli) resulted in viable mutant cells characterized by a significant increase in carotenoid production |
| 12/27/2007 | US20070298482 Process for increased patchulol content in essential oil of pogostemon cablin |
| 12/27/2007 | US20070298476 Pentose-fermentative transformed Zymobacter microorganisms |
| 12/27/2007 | US20070298475 Preparation of Vanillin from Microbial Transformation Media by Extraction by Means Supercritical Fluids or Gases |
| 12/27/2007 | US20070298473 Pet family of efflux proteins |
| 12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
| 12/27/2007 | US20070298469 N-epsilon-acyl-l-lysine-specific aminoacylase |
| 12/27/2007 | US20070298468 Method of preparing 2-deoxyribose 5-phosphate |
| 12/27/2007 | US20070298467 Method of preparing 2-deoxyribose 5-phosphate |
| 12/27/2007 | US20070298466 Method For The Construction Of Randomized Gene Sequence Libraries In Cells |
| 12/27/2007 | US20070298461 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 12/27/2007 | US20070298460 Novel receptor that causes cell death |
| 12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
| 12/27/2007 | US20070298457 Soluble endoproteases for the in vitro processing of recombinant proteins |
| 12/27/2007 | US20070298452 Selective growth media N4 agars that include a combination of high levels of yeast extract; provides the ability to detect Salmonella spp. and Shigella spp. with almost identical sensitivity while alleviating false-negative and false-positive problems |
| 12/27/2007 | US20070298414 Engineering Enzymes Through Genetic Selection |
| 12/27/2007 | US20070298145 Enzymes |
| 12/27/2007 | US20070298052 Drying Process for Presserving an Active Agent as a Higly Viscous Liquid |
| 12/27/2007 | US20070298050 direct replacement of chloroplast Photosystem II (PSII) reaction center protein coding regions to achieve expression of recombinant protein above 5% of total protein; edible algae; mammary associated serum amyloid A3 (M-SAA3) |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298036 PRO71238 Polypeptides |
| 12/27/2007 | US20070298019 Novel lactobacillus bulgaricus strain and compositions |
| 12/27/2007 | US20070298014 Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinants |
| 12/27/2007 | CA2659691A1 Modified beta-lactamase and method for its preparation |
| 12/27/2007 | CA2658926A1 Cosmid vector for transforming plant and use thereof |
| 12/27/2007 | CA2656707A1 Nucleic acid molecules encoding an enzyme that degrades long chain n-alkanes |
| 12/27/2007 | CA2655882A1 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene |
| 12/27/2007 | CA2655544A1 Fatty acid hydroxylases and uses thereof |
| 12/27/2007 | CA2653571A1 Composition and methods for improving the production of fermentation operations |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870459A1 Methods for producing polypeptides by regulating polypeptide association |
| 12/26/2007 | EP1870454A1 Method for producing dipeptide |
| 12/26/2007 | EP1870453A1 Novel protease, microorganism producing the same, and application thereof |
| 12/26/2007 | EP1870449A1 Method of concentrating and disrupting cells or viruses |
| 12/26/2007 | EP1870448A1 Solar power from sea |
| 12/26/2007 | EP1869464A2 Rage/diaphanous interaction and related compositions and methods |
| 12/26/2007 | EP1869179A2 Method for treating a sample that contains biomolecules |
| 12/26/2007 | EP1869177A2 A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure |
| 12/26/2007 | EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 12/26/2007 | EP1869161A1 Method for the preparation of anallergic probiotic bacterial cultures and related use |
| 12/26/2007 | EP1869160A2 Gene inactivated mutants with altered protein production |
| 12/26/2007 | EP1869078A2 Process for the purification of recombinant granulocyte-colony stimulating factor |
| 12/26/2007 | EP1868622A1 Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| 12/26/2007 | EP1608764B1 A process for the production of l-amino acids using strains of the enterobacteriaceae family which overexpress the galp gene, coding for a galactose proton symporter |
| 12/26/2007 | EP1572982B1 Microorganism producing 5 -xanthylic acid |
| 12/26/2007 | EP1427744B1 A system for antibody expression and assembly |
| 12/26/2007 | EP1287024B1 Virulence genes, proteins, and their use |
| 12/26/2007 | EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 12/26/2007 | EP1177305B1 Method for producing a recombinant protein |